<unk> , sold under the brand names Prezcobix (US) and Rezolsta (EU), is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains<unk>  and<unk> .<unk>  is an HIV protease inhibitor and<unk>  increases the effectiveness of<unk>  by blocking its metabolism by the enzyme CYP3A.<unk>  was approved for use in the European Union in November 2014, and for use in the United States in January 2015.
Darunavir/cobicistat
Atazanavir/cobicistat
Atazanavir/ritonavir
Elbasvir/grazoprevir
Nirmatrelvir/ritonavir
Cabotegravir/rilpivirine
Dolutegravir/rilpivirine
Abacavir/lamivudine